The DAC moiety is a maleimidoproprionic-acid linker positioned at the C-terminus of the modified GHRH(1-29) parent peptide
Patients with A1C greater than 9% are at risk of life-threatening severe hyperglycemia and outcomes such as retinopathy, neuropathy, and diabetic ulcers
In 2013, lab tests revealed that an antioxidantalpha-lipoic acidhelped to protect retinal ganglion cells, which are essential for vision and damaged by glaucoma, from oxidative stress
- Improvement of stretch marks, acne scars, and epidermal damage
At the pharmacy Ask to see the medication before purchasing
Safe discontinuation of tirzepatide requires medical oversight and individualized planning, even though formal tapering is not pharmacologically necessary